Dennis Cho - 04 Nov 2024 Form 4 Insider Report for Twist Bioscience Corp (TWST)

Role
Senior Vice President, Chief Legal Officer & Corporate Secretary
Signature
/s/ Judy Yan, as Attorney-in-Fact for Dennis Cho
Issuer symbol
TWST
Transactions as of
04 Nov 2024
Net transactions value
-$27,391
Form type
4
Filing time
06 Nov 2024, 17:06:32 UTC
Previous filing
04 Oct 2024
Next filing
15 Nov 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TWST Common Stock Award $0 +12,000 +16% $0.000000 87,289 04 Nov 2024 Direct F1
transaction TWST Common Stock Award $0 -7,851 -7.6% $0.000000 95,140 04 Nov 2024 Direct F1
transaction TWST Common Stock Sale $27,391 -659 -0.69% $41.56 94,481 04 Nov 2024 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents performance stock units for which target criteria was determined to have been met on November 4, 2024. 60% of the PSUs remain subject to time-based vesting and will vest on October 1,2025, subject to continued service or acceleration of vesting as provided in the award agreement.
F2 Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person.

Remarks:

Senior Vice President, Chief Legal Officer & Corporate Secretary